Neurodevelopmental outcomes following antiretroviral medication exposure in utero
Researchers affiliated to the Harvard T.H. Chan School of Public Health have published an analysis of data from the US-based pediatric HIV/AIDS cohort study investigating the risk of neurodevelopmental problems in HIV-exposed uninfected 5-year-old children exposed to ART medication in utero. More information can be found here.